Drug Reference

meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle

Brand names

Bexsero

Available as

0.5 ML · Prefilled Syringe

Multi-ingredient product

Meningococcal Group B VaccineNeisseria Meningitidis Serogroup B Recombinant Fhbp Fusion Protein AntigenNeisseria Meningitidis Serogroup B Recombinant Nhba Fusion Protein AntigenNeisseria Meningitidis Serogroup B Strain Nz98254 Outer Membrane Vesicle

This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.

Current FDA labels (DailyMed)

BEXSERO (NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN AND NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN) INJECTION, SUSPENSION [GLAXOSMITHKLINE BIOLOGICALS SA]

2 marketed products on record (RxNorm)

Authoritative sources

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.